International Journal of Colorectal Disease

, Volume 25, Issue 10, pp 1221–1229 | Cite as

Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers

  • Min-Hoe Chew
  • Shen-Ann Eugene Yeo
  • Zhi-Peng Ng
  • Kiat-Hon Lim
  • Poh-Koon Koh
  • Kheng-Hong Ng
  • Kong-Weng Eu
Original Article

Abstract

Introduction

Conflicting data on the clinicopathological characteristics as well as prognosis and survival of signet ring cell (SRC) and mucinous adenocarcinomas (MA) of the colorectum persist.

Methods

Consecutive patients (2,764) with sporadic colorectal cancer from 1999 to 2005 were evaluated. The clinicopathological characteristics of these patients were reviewed. Univariate analysis was performed, and survival curves were constructed using the Kaplan–Meier method. Multivariate analysis assessed independent prognostic factors.

Results

The incidence of MA and SRC is 6% and 1.1%, respectively. MA and SRC tend to occur in patients aged ≤50 years (SRC 33%, MA 22%, ordinary adenocarcinomas (OA) 14%, p = 0.001) and are more commonly right-sided (MA 30%, SRC 27%, OA 19%, p = 0.001) than OA. SRC tend to be poorly differentiated (SRC 77%, MA 26%, OA 6%, p < 0.0001) and have a higher risk of recurrence (SRC 40%, MA 26%, OA 6%, p < 0.0001). SRC and MA are more likely to have locally advanced lesions (T3/T4; SRC 100%, MA 90%, OA 83%, p = 0.002) and lymph node metastases (SRC 89%, MA 61%, OA 52%, p < 0.0001) and present with an advanced stage at diagnosis (stage III/IV SRC 94%, MA 67%, OA 56%, p < 0.0001). SRC has poorer 5-year cancer-specific survival (CSS; 11.1%, 95% confidence interval (CI) 0–22.9%) compared with MA (46.8%, 95% CI 38.6–55.0%) and OA (58.7%, 95% CI 56.5–60.9%, p < 0.001). In a multivariate analysis, SRC is an independent poor prognostic factor (HR 1.9, 95% CI 1.1–3.0) but MA is not.

Conclusion

SRC and MA demonstrate clinicopathologic characteristics suggestive of a different biology compared with OA. In our dataset, SRC has a significantly poorer CSS whereas survival rates for MA are similar to OA. These characteristics are similar in both Asian and Western studies reported. Asian reports however suggest a lower incidence of MA.

Keywords

Colorectal mucinous adenocarcinoma Signet ring cell Survival 

Notes

Acknowledgments

The authors would like to thank the following people in the preparation of the manuscript: (a) Singapore Polyposis Registry coordinator: Ms Loi TT, Carol, RN Msc (Healthcare); (b) Senior Biostatistician, Department of Clinical Research Singapore General Hospital: Ms Fook-Chong MC, Stephanie, BSc MSc(McGill) CStat; (c) Rest of the contributory authors to the manuscript: Dr Ming-Hian Kam, Dr Hak-Mien Quah, Dr Jit-Fong Lim, Dr Kok-Sun Ho, and A/Prof Choong-Leong Tang.

References

  1. 1.
    Chia KS, Lee HP, Seow A, Shanmugaratnam K. Trends in cancer incidence in Singapore, 1968–1992. Singapore Cancer Registry Report No. 4:114Google Scholar
  2. 2.
    Hamilton SR, Aaltonen LA (2000) WHO classification of tumours: pathology and genetics of tumours of the digestive system. International Agency for Research on Cancer, LyonGoogle Scholar
  3. 3.
    Xie L, Villeneuve PJ, Shaw A (2009) Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol 34(4):1109–1115CrossRefPubMedGoogle Scholar
  4. 4.
    Maksimović S (2007) Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh 61(1):26–29, English abstractPubMedGoogle Scholar
  5. 5.
    Kang H, O’Connell JB, Maggard MA, Sack J, Ko CY (2005) A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48(6):1161–1168CrossRefPubMedGoogle Scholar
  6. 6.
    Papadopoulos VN, Michalopoulos A, Netta S, Basdanis G, Paramythiotis D, Zatagias A, Berovalis P, Harlaftis N (2004) Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol 8(Suppl 1):s123–s125CrossRefPubMedGoogle Scholar
  7. 7.
    Adell R, Marcote E, Segarra MA, Pellicer V, Gamón R, Bayón AM, Canales M, Torner A (2002) Is mucinous colorectal adenocarcinoma a distinct entity? Gastroenterol Hepatol 25(9):534–540PubMedGoogle Scholar
  8. 8.
    Consorti F, Lorenzotti A, Midiri G, Di Paola M (2000) Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 73(2):70–74CrossRefPubMedGoogle Scholar
  9. 9.
    Secco GB, Fardelli R, Campora E, Lapertosa G, Gentile R, Zoli S, Prior C (1994) Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 51(1):30–34CrossRefPubMedGoogle Scholar
  10. 10.
    Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE (1993) Mucinous carcinoma—just another colon cancer? Dis Colon Rectum 36(1):49–54CrossRefPubMedGoogle Scholar
  11. 11.
    Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, Zhan WH (2009) Clinicopathologic features and survival of patients with mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl) 122(13):1486–1491Google Scholar
  12. 12.
    Lee WS, Chun HK, Lee WY, Yun SH, Cho YB, Yun HR, Park SH, Song SY (2007) Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg 194(3):294–298CrossRefPubMedGoogle Scholar
  13. 13.
    Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS (2004) Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum 47(1):78–85CrossRefPubMedGoogle Scholar
  14. 14.
    Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, Kodera Y, Yamamura Y (2003) Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46(2):160–167CrossRefPubMedGoogle Scholar
  15. 15.
    Nozoe T, Anai H, Nasu S, Sugimachi K (2000) Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75(2):103–107CrossRefPubMedGoogle Scholar
  16. 16.
    Wu CS, Tung SY, Chen PC, Kuo YC (1996) Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol 11(1):77–81CrossRefPubMedGoogle Scholar
  17. 17.
    Laufman H, Saphir O (1951) Primary linitis plastic type of carcinoma of the colon. AMA Arch Surg 62:79–91PubMedGoogle Scholar
  18. 18.
    Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453–1456CrossRefPubMedGoogle Scholar
  19. 19.
    AJCC (2002) Cancer staging manual, 6th edn. Springer, New YorkGoogle Scholar
  20. 20.
    Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM (1999) Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum 42:1176–1180CrossRefPubMedGoogle Scholar
  21. 21.
    Psathakis D, Schiedeck TH, Krug F, Oevermann E, Kujath P, Bruch HP (1999) Ordinary colorectal adenocarcinoma vs primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade and stage. Dis Colon Rectum 42:1618–1625CrossRefPubMedGoogle Scholar
  22. 22.
    Ooi BS, Ho YH, Eu KW, Seow Choen F (2001) Primary colorectal signet-ring cell carcinoma in Singapore. ANZ J Surg 71:703–706CrossRefPubMedGoogle Scholar
  23. 23.
    Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, Fakih MG (2008) Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 51(1):50–55CrossRefPubMedGoogle Scholar
  24. 24.
    Chen JS, Hsieh PS, Hung SY, Tang R, Tsai WS, Changchien CR, Lin PY, Wang JY, Yeh CY (2004) Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis 19(2):102–107CrossRefPubMedGoogle Scholar
  25. 25.
    Makino T, Tsujinaka T, Mishima H, Ikenaga M, Sawamura T, Nakamori S et al (2006) Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases. Hepatogastroenterology 53(72):845–849PubMedGoogle Scholar
  26. 26.
    Sugarbaker PH (2001) Mucinous colorectal carcinoma. J Surg Oncol 77:282–283CrossRefPubMedGoogle Scholar
  27. 27.
    Börger ME, Gosens MJ, Jeuken JW, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID (2007) Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol 212(3):278–286CrossRefPubMedGoogle Scholar
  28. 28.
    Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y et al (2003) Immunohistochemical and mutational analysis of beta-catenin, Ki-ras and p53 in two subtypes of colorectal mucinous carcinoma. Clin Cancer Res 9(15):5660–5665PubMedGoogle Scholar
  29. 29.
    Hanski C, Tiecke F, Hummel M et al (1996) Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett 103(2):163–170CrossRefPubMedGoogle Scholar
  30. 30.
    King-Yin Lam A, Ong K, Ho YH (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 49(9):1275–1283CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Min-Hoe Chew
    • 1
  • Shen-Ann Eugene Yeo
    • 1
  • Zhi-Peng Ng
    • 2
  • Kiat-Hon Lim
    • 3
  • Poh-Koon Koh
    • 1
  • Kheng-Hong Ng
    • 1
  • Kong-Weng Eu
    • 1
  1. 1.Department of Colorectal SurgerySingapore General HospitalSingaporeSingapore
  2. 2.Yong Loo Lin School of MedicineNational University of SingaporeSingaporeSingapore
  3. 3.Department of PathologySingapore General HospitalSingaporeSingapore

Personalised recommendations